Physician profile
Andrew C Nelson
NPI 1760700777
$2,580.76
in general payments reported to CMS, 2019-2025
5 companies · $1,704 in 2025
The $1,704 reported for 2025 was more than what a typical Molecular Genetic Pathology (Pathology) provider received nationally (typical 2025 total: $225).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $826 · 2022: $50.56 · 2025: $1,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,575 · Food and Beverage: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,575.00 |
| Food and Beverage | $129.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Sequencing Solutions, INC. | $1,575.00 | 2025 | |
| Veracyte, INC. | $825.95 | 2021 | |
| Roche Diagnostics International LTD | $100.91 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $50.56 | 2022 | |
| Promega Corporation | $28.34 | 2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.